A fine decision tree consisted of CK5/6, IMP3 and TTF1 for cytological diagnosis among reactive mesothelial cells, metastatic adenocarcinoma of lung and non-lung origin in pleural effusion.
Authors:
- 15 August 2014
- journal article
- research article
- Vol. 7 (9) , 5810-8
Abstract
The utility of combination with CK5/6, IMP3 and TTF1 to differentiate among reactive mesothelial cells (RMs), metastatic adenocarcinoma of lung (LAC) and non-lung (NLAC) origin was investigated by using immunocytochemistry (ICC) and conventional PCR (C-PCR) in pleural effusion. A total of 108 cell blocks (32 RMs, 51 LAC and 25 NLAC were evaluated by ICC for CK5/6, IMP3 and TTF1 protein expression. In addition, we further performed C-PCR for amplification of CK5/6, IMP3 and TTF1 DNA from 28 specimens (9 MAC and 7 RMs, 6 LAC and 6 NLAC) for molecular diagnosis. CK5/6 staining was observed in the majority of reactive specimens (78.1%) and was rare in adenocarcinoma cells (14.5%), whereas the opposite was true for IMP3 and TTF1. We found a high frequency of TTF1 positivity (76.5%) in LAC, but not in NLAC (4.0%); while there was no significant difference of IMP3 expression in LAC (88.2%) and NLAC (88.0%). The 487 bp DNA fragments of IMP3 was expected to be amplified in 6/9 of adenocarcinoma cases showed negative in ICC; and the 394 bp DNA fragments of CK5/6 was also expected to be amplified in 4/7 of RMs cases showed negative in ICC. Consistent with ICC results, there was significant difference of TTF1 expression in the LAC and NLAC compared with IMP3 expression. The combination with CK5/6, IMP3 and TTF1 immunostaining appears to be useful to improve the accuracy of cytological diagnoses between RMs, metastatic adenocarcinoma of lung and non-lung origin in pleural effusion. In addition, C-PCR may act as a useful supplemental approach for ICC, especially negative cases in ICC for differential cytological diagnosis.Keywords
This publication has 38 references indexed in Scilit:
- Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinomaJournal of Experimental & Clinical Cancer Research, 2013
- IMP3 and GLUT-1 Immunohistochemistry for Distinguishing Benign From Malignant Mesothelial ProliferationsAmerican Journal of Surgical Pathology, 2013
- Diagnostic value of tumor markers in lung adenocarcinoma‐associated cytologically negative pleural effusionsCancer Cytopathology, 2013
- Proliferative index using Ki-67 index in reactive mesothelial versus metastatic adenocarcinoma cells in serous fluidAdvanced Biomedical Research, 2012
- Multiplex PCR for the concurrent detection and differentiation of Salmonella spp., Salmonella Typhi and Salmonella TyphimuriumTropical Medicine and Health, 2011
- Thyroid Transcription Factor 1 Is an Independent Prognostic Factor for Patients With Stage I Lung AdenocarcinomaJournal of Clinical Oncology, 2009
- Diagnosis and management of malignant pleural effusionsRespirology, 2007
- Scrub Typhus in HimalayasEmerging Infectious Diseases, 2006
- Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificityLaboratory Investigation, 2006
- Thyroid transcription factor 1 in pulmonary adenocarcinomaJournal of Clinical Pathology, 2004